Autopsy report · NCT01680237
Cognitive Behavior Therapy vs Exposure in Vivo in the Treatment of Panic Disorder With Agoraphobia
Cause of deathStaffing, sites or logistics
“Retirement of one of the PIs and participation in another multi center study, within which the same patient inclusion criteria were used.”
Life of this trial
- Registered 10 months after it had already started.
- Ran for about 12 years 1 month before it stopped.
- 130 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- Ruhr University of Bochum
- Sponsor type
- University, hospital or other
- Conditions
- Panic Disorder With Agoraphobia
- Interventions
- Cognitive behavior therapy; Exposure in-vivo
- Participants
- 130
- Sites
- 1
- Countries
- Germany
Trials that died the same way
- Over Active Bladder Instillation Study - Botox
“Study terminated early due to PI's extended medical leave.” - Treatment of Strongyloides Infection
“The original study PI passed away. Primary and Study Completion dates revised to reflect last participant examination date.” - A Study of the Use of IV Scopolamine to Augment the Efficacy of Electroconvulsive Therapy (ECT)
“This was an inpatient study, but PI left inpatient service at MGH” - Yttrium-90 (TARE-Y90) in Children, Adolescents, and Young Adults With Liver Tumors
“PI left organization and discontinued study” - Everyday Activity Shoes: a Quantification of Impact Forces While Walking
“The study was terminated due to the PI leaving for sabbatical.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.